Study genetic risks in children with malignant brain tumors
Part of Brain & nervous system, Cancer clinical trials.
This study looks at genetic (DNA/molecular) features of malignant brain tumors in children. It may help doctors better understand tumor risk patterns and guide future treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is 0 to 18 years old and has a confirmed malignant brain tumor
- The tumor type must be one of the listed types (like medulloblastoma, glioma, ependymoma, or others)
- Surgery to remove the tumor is planned, and your child is eligible to receive that resection
- Tumor diagnosis must be confirmed by the hospital’s pathology (microscope) review
- Your child has not had prior chemotherapy or radiation therapy (except steroids)
- There must be usable tumor tissue from surgery for genetic testing, and you agree to join and follow study visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at brain tumor samples from children and young adults after surgery to learn more about the tumors and find better treatments. It may help researchers develop new therapies for these tumors.
This study looks at how young people with certain brain tumors respond to treatment. It aims to understand why some tumors resist therapy, which may help improve future treatments.
This study tests a personalized treatment plan for children and young adults whose medulloblastoma or ependymoma has come back. It aims to guide doctors using new tissue from surgery or biopsy after earlier treatments are fully finished.
This study looks at tumor tissue from children and young adults with a specific type of brain tumor called medulloblastoma. The goal is to understand the tumor better and find new ways to treat it.
This Phase 2 trial tests how doctors choose treatment for infants and young children with newly diagnosed medulloblastoma, based on MRI/CSF staging and lab testing of the tumor. It may help by matching therapy intensity to the child’s specific risk level and tumor type.
This trial observes where medulloblastoma tumors first appear and how they grow during surgery. It helps doctors better understand these rare childhood and adult brain tumors.
Hear when a new Medulloblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.